David A Santos Rigel Pharmaceuticals Inc (RIGL) insider trading activity

RIGL Quotes by TradingView

David A Santos is EVP, Chief Commercial Officer of RIGEL PHARMACEUTICALS INC. Currently has a direct ownership of 349,093 shares of RIGL, which is worth approximately $4.65 Million. The most recent transaction as insider was on Feb 05, 2024, when has been sold 8,918 shares (Common Stock) at a price of $1.14 per share, resulting in proceeds of $10,166. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 349K
0% 3M change
141.4% 12M change
Total Value Held $4.65 Million

David A Santos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2024
SELL
Open market or private sale
$10,166 $1.14 p/Share
8,918 Reduced 2.49%
349,093 Common Stock
Feb 02 2024
SELL
Open market or private sale
$6,329 $1.13 p/Share
5,601 Reduced 1.54%
358,011 Common Stock
Jan 23 2024
BUY
Grant, award, or other acquisition
-
209,000 Added 36.5%
363,612 Common Stock
Feb 02 2023
SELL
Open market or private sale
$8,944 $1.66 p/Share
5,388 Reduced 3.59%
144,612 Common Stock
Jan 26 2023
BUY
Grant, award, or other acquisition
-
80,000 Added 34.78%
150,000 Common Stock
Jan 24 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 45.45%
60,000 Common Stock
DAS

David A Santos

EVP, Chief Commercial Officer
South San Francisco, CA

Track Institutional and Insider Activities on RIGL

Follow RIGEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RIGL shares.

Notify only if

Insider Trading

Get notified when an Rigel Pharmaceuticals Inc insider buys or sells RIGL shares.

Notify only if

News

Receive news related to RIGEL PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RIGL